LINC02556

Across TCGA pan-cancer cohorts, LINC02556 RNA is linked to patient survival in 19 of 34 cancer types, making it the most broadly survival-associated LINC02556 data layer.

The strongest signal is observed in uveal melanoma (UVM), where higher LINC02556 RNA is associated with worse overall survival. In most high-consensus cancer types, elevated LINC02556 expression acts as an unfavorable survival marker, although some lineages such as MESO and LAML show a favorable association.

UVM, UCS, and MESO are the cancer types where LINC02556 RNA most reproducibly stratifies survival.

RNA survival associations by lineage

Ranked by sampling consensus. AUC1 and AUC2 indicate survival in the high- and low-expression groups, respectively; the lower AUC marks the poorer-surviving group. p-values are from the log-rank test.

Lineage	Measure	Split	Stage	AUC1 high	AUC2 low	p	Sampling consensus
UVM	OS	Tertile	III,IV	0.241	0.765	.002	48	view →
UCS	OS	Tertile	II,III,IV	0.257	0.647	.001	46	view →
MESO	OS	Quartile	All	0.762	0.327	.008	38	view →
ACC	DFS	Tertile	II,III,IV	0.193	0.639	.008	27	view →
THYM	DFS	Tertile	All	0.805	0.945	.001	20	view →
READ	DFS	Tertile	IV	0.357	0.682	.011	18	view →
KICH	DFS	Tertile	II,III,IV	0.515	0.859	.010	14	view →
CESC	OS	Median	All	0.837	0.903	.021	14	view →
LAML	DFS	Tertile	All	0.670	0.471	.018	14	view →
STAD	OS	Tertile	All	0.719	0.616	.021	12	view →
COAD	DFS	Tertile	IV	0.249	0.508	.012	9	view →
LUSC	DFS	Quartile	All	0.251	0.430	.010	8	view →

Pink = unfavorable, green = favorable. Showing the 12 strongest of 19 lineages.

LINC02556–UVM (OS)

Open the UVM breakdown →